Clinical Research Directory
Browse clinical research sites, groups, and studies.
Yeast Mannans and Stool Frequency
Sponsor: University of Florida
Summary
Findings from an open-label pilot study of 20 adults suggested that supplementation with 15 g/day of yeast mannans was highly tolerable and demonstrated specific modulation of the microbiota and increased stool frequency in a subset of subjects reporting ≤1 stool per day at baseline. The primary aim of this randomized, double-blind, controlled trial is to determine if yeast mannan supplementation at 12 g/day will increase stool frequency in generally healthy adults reporting ≤1 stool per day. Secondary aims will determine the effect of yeast mannans on intestinal transit time, gastrointestinal symptoms, fecal microbiota composition, and urinary and fecal metabolomics.
Official title: Efficacy of Yeast Mannan Supplementation on Increasing Stool Frequency in Generally Healthy Adults: A Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2025-07-17
Completion Date
2026-06-30
Last Updated
2026-02-04
Healthy Volunteers
Yes
Conditions
Interventions
Yeast mannan
Yeast cell wall fraction of manno-oligosaccharides and mannoproteins supplemented at 12 g/day.
Control (placebo)
A supplement containing yeast protein, yeast extract, and maltodextrin, provided at 12 g/day.
Locations (1)
Department of Food Science and Human Nutrition
Gainesville, Florida, United States